𝔖 Bobbio Scriptorium
✦   LIBER   ✦

UICC multidisciplinary project on breast cancer. Management of early and advanced breast cancer

✍ Scribed by J. L. Hayward; R. D. Rubens


Publisher
John Wiley and Sons
Year
1987
Tongue
French
Weight
540 KB
Volume
39
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


UICC multidisciplinary project on breast
✍ A. B. Miller; R. D. Bulbrook πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 French βš– 532 KB

Breast cancer is hormonally mediated and oestrogens are the prime agents in tumour expression. This was the main conclusion of the meeting in June, 1980, of the Multidisciplinary Project on Breast Cancer of the International Union Against Cancer (Miller and Bulbrook, 1980). The present report conce

UICC project on screening for cancer: Re
✍ N. E. Day; C. J. Baines; J. Chamberlain; M. Hakama; A. B. Miller; P. Prorok πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 French βš– 586 KB

The 4th workshop of the UICC project on screening for cancer was held in Helsinki, Finland on April 7-9, 1986. In developed countries there are more data available from controlled trials on the effectiveness of screening for breast cancer than for any other cancer. Nevertheless, full information is

Surgical management of clinically early
✍ David W. Kinne πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 608 KB

The management of patients with primary operable or potentially curable breast cancer continues to be controversial. Modified radical mastectomy is still considered the standard approach for patients with this problem, but certain carefully selected patients with smaller tumors are being treated in

Diethylstilbestrol revisited in advanced
✍ Boyer, Michael J. ;Tattersall, Martin H. N. πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 361 KB

## Abstract Prior to the introduction of tamoxifen, diethylstilbestrol (DES) was widely used as the first‐line endocrine therapy in postmenopausal women with advanced breast cancer. Since randomized trials reported that tamoxifen has a similar response rate but fewer side effects than DES, its use